Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
 | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
 |  |  |  | ||||||
| ABL1 | STAT5A | STAT5A, STAT5: Signal transducer and activator of transcription 5A | 345.0 | Evidence | |||||
| ABL1 | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 299.0 | Evidence | |||||
| ABL1 | CRKL | CRKL: Crk-like protein | 275.0 | Evidence |
|
||||
| ABL1 | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 258.0 | Evidence | |||||
| ABL1 | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 221.0 | Evidence | |||||
| ABL1 | PDGFRA | PDGFRA: Alpha-type platelet-derived growth factor receptor precursor | 206.0 | Evidence | |||||
| ABL1 | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 206.0 | Evidence | |||||
| ABL1 | STAT5B | STAT5B: Signal transducer and activator of transcription 5B | 206.0 | Evidence | |||||
| ABL1 | INSR | INSR: Insulin receptor precursor | 147.0 | Evidence | |||||
| ABL1 | NCK2 | NCK2: Cytoplasmic protein NCK2 | 143.0 | Evidence | |||||
| ABL1 | TYK2 | TYK2: Non-receptor tyrosine-protein kinase TYK2 | 137.0 | Evidence | |||||
| ABL1 | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 137.0 | Evidence |
|
||||
| ABL1 | STAT1 | STAT1: Signal transducer and activator of transcription 1-alpha/beta | 135.0 | Evidence | |||||
| ABL1 | TEC | TEC, PSCTK4: Tyrosine-protein kinase Tec | 135.0 | Evidence | |||||
| ABL1 | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 135.0 | Evidence |
|
||||
| ABL1 | KIT | KIT: Mast/stem cell growth factor receptor precursor | 125.0 | Evidence |
|
||||
| ABL1 | STAT3 | 119.0 | Evidence | ||||||
| ABL1 | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 119.0 | Evidence |
|
||||
| ABL1 | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 119.0 | Evidence | |||||
| ABL1 | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 119.0 | Evidence |
|
||||
| ABL1 | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 119.0 | Evidence |
|
||||
| ABL1 | SYK | SYK: Tyrosine-protein kinase SYK | 116.0 | Evidence | |||||
| ABL1 | STAT6 | STAT6: Signal transducer and activator of transcription 6 | 109.0 | Evidence | |||||
| ABL1 | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 109.0 | Evidence |
|
||||
| ABL1 | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 109.0 | Evidence |
|
||||
| ABL1 | CSK | CSK: Tyrosine-protein kinase CSK | 109.0 | Evidence | |||||
| ABL1 | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 109.0 | Evidence | |||||
| ABL1 | VAV1 | VAV1, VAV: Proto-oncogene vav | 109.0 | Evidence | |||||
| ABL1 | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 107.0 | Evidence | |||||
| ABL1 | IGF1R | IGF1R: Insulin-like growth factor 1 receptor precursor | 102.0 | Evidence | |||||
| ABL1 | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 101.0 | Evidence | |||||
| ABL1 | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 101.0 | Evidence |
|
||||
| ABL1 | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 89.30 | Evidence |
|
||||
| ABL1 | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 89.20 | Evidence | |||||
| ABL1 | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 89.20 | Evidence | |||||
| ABL1 | EGFR | EGFR, ERBB1: Epidermal growth factor receptor precursor | 89.20 | Evidence | |||||
| ABL1 | SH2D2A | SH2D2A, SCAP, TSAD, VRAP: SH2 domain-containing protein 2A | 88.80 | Evidence | |||||
| ABL1 | APS | SH2B2, APS: SH2B adapter protein 2 | 88.80 | Evidence | |||||
| ABL1 | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 88.80 | Evidence | |||||
| ABL1 | LYN | LYN: Tyrosine-protein kinase Lyn | 88.80 | Evidence | |||||
| ABL1 | LCK | LCK: Proto-oncogene tyrosine-protein kinase LCK | 88.80 | Evidence | |||||
| ABL1 | HCK | N/A | 78.20 | Evidence |
|
||||
| ABL1 | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 70.50 | Evidence | |||||
| ABL1 | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 66.50 | Evidence | |||||
| ABL1 | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 66.50 | Evidence | |||||
| ABL1 | MET | MET: Hepatocyte growth factor receptor precursor | 58.60 | Evidence | |||||
| ABL1 | GRB10 | N/A | 56.20 | Evidence | |||||
| ABL1 | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 35.30 | Evidence | |||||
| ABL1 | BRDG1 | STAP1, BRDG1: Signal-transducing adaptor protein 1 | 24.10 | Evidence | |||||
| ABL1 | CTTN | CTTN, EMS1: Src substrate cortactin | 22.80 | Evidence | |||||
| ABL1 | CD2AP | CD2AP: CD2-associated protein | 22.80 | Evidence | |||||
| ABL1 | GRAP | GRAP: GRB2-related adapter protein | 20.70 | Evidence | |||||
| ABL1 | SH2D1A | SH2D1A, DSHP, SAP: SH2 domain-containing protein 1A | 17.90 | Evidence | |||||
| ABL1 | DOK1 | DOK1: Docking protein 1 | 17.30 | Evidence |
|
||||
| ABL1 | WASPIP | N/A | 17.10 | Evidence | |||||
| ABL1 | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 17.10 | Evidence | |||||
| ABL1 | SGK2 | SGK2: Serine/threonine-protein kinase Sgk2 | 15.00 | Evidence | |||||
| ABL1 | STAM2 | STAM2: Signal transducing adapter molecule 2 | 14.70 | Evidence | |||||
| ABL1 | HCLS1 | HCLS1, HS1: Hematopoietic lineage cell-specific protein | 14.70 | Evidence | |||||
| ABL1 | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 14.20 | Evidence | |||||
| ABL1 | PRKCE | PRKCE, PKCE: Protein kinase C epsilon type | 13.10 | Evidence | |||||
- 
-